UBI Pharma Inc. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was TWD 423.863 million compared to TWD 332.837 million a year ago. Operating loss was TWD 255.750 million compared to TWD 179.897 million a year ago. Net loss was TWD 240.966 million compared to TWD 167.171 million a year ago. Basic loss per share was TWD 1.7 compared to TWD 1.18 a year ago.